The engagement of PD-1 on T cells by PD-L1 expressed on tumor cells or APCs results in the dampening of T cell receptor signaling, which allows for the moderation of immune responses in order to prevent overactivity [52]. This evidence concerns the gene CD274 and neoplasm.